PharmaPendium Classic

PharmaPendium offers you unrivalled insight into the entire history of drug development.

With the FDA CDER FOI drug approval document collection prior to 1992 now indexed and fully searchable - the addition of the FDA classic collection means that PharmaPendium has complete coverage of all approved drugs since records began – so you don’t miss a thing.

PharmaPendium Classic offers:

• The ability to explore the entire history of drug development data in a single search – saving you valuable time
• Comprehensive, high quality experimental data
• The ability to find a wealth of data not published elsewhere – so you can be confident that you are as informed as your competitors.

How will this benefit you?
 

Discovery phase?

Using this historic drug library, you can quickly and easily search all FDA drug efficacy, safety and pharmacokinetics information since 1938.  And for the first time in over 50 years you can scour the available biology and chemistry data on these older drugs to look for new modeling data sets or even repurposing opportunities.

Development: Preclinical Safety, Risk Assessment?

With many more recent documents citing older (pre-1992) documents - and the animal studies contained within them - every citation of a previous FDA document is now traceable, searchable and viewable – so you don’t miss a thing.

Pharmacokinetics?

PharmaPendium contains incredibly detailed exposure data (Cmax, Tmax, T1/2, AUC, Vss, etc) that is almost never published and is not available via any other commercial resource. The addition of the FDA classic collection enhances this highly valuable pharmacokinetics tool, further strengthening your market position.